Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease

Internal Medicine Journal

Volumn 35, Issue 6, 2005, Pages 331-335

  Zeng, B ^a   Prasan, A ^a   Fung, K C ^a   Solanki, V ^a   Bruce, D ^a   Freedman, S B ^a   Brieger, David ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Coronary artery disease; Inflammation; Matrix metalloproteinase; Myocardial injury; Zymography

Indexed keywords

C REACTIVE PROTEIN; GELATINASE A; GELATINASE B; MOLECULAR MARKER; TROPONIN T;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DRUG BLOOD LEVEL; FEMALE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; INFLAMMATION; INFLAMMATORY CELL; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY; ZYMOGRAPHY;

AGED; ANGINA PECTORIS; C-REACTIVE PROTEIN; CORONARY DISEASE; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; SYNDROME; TROPONIN T;

EID: 20444442388     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00822.x     Document Type: Article

References (17)

1. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92 KD gelatinase in human atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation 1995; 91: 2127-31.
2. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493-503.
3. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995; 92: 1565-9.
4. Li Z, Li L, Zielke HR, Cheng L, Xiao R, Crow MT et al. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 1996; 148: 121-8.
5. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F et al. Peripheral blood levels of matrix metalloproteases -2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998; 32: 368-72.
6. Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 2001; 141: 211-17.
7. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S et al. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 2001; 69: 851-9.
8. Heussen C & Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980; 102: 196-202.
9. Jacob MP, Cazaubon M, Scemama A, Prie D, Blanchet F, Guillin MC et al. Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins. Circulation 2002; 106: 535-8.
10. Sumii T & Lo EH. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002; 33: 831-6.
11. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
12. Muller-Bardorff M, Hallermayer K, Schroder A, Ebert C, Borgya A, Gerhardt W et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 1997; 43: 458-66.
13. Galis Z, Khatri J. Matrix metalloproteinases in vascular remodeling and atherogenesis. The good, the bad, and the ugly. Circ Res 2002; 90: 251-62.
14. Jung K, Laube C, Lein M, Lichtinghagen R, Tschesche H, Schnorr D et al. Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. Clin Chem 1998; 44: 1060-2.
15. Leber TM, Balkwill FR. Zymography: a single-step staining method for quantitation of proteolytic activity on substrate gels. Anal Biochem 1997; 249: 24-8.
16. Cleutjens JP. The role of matrix metalloproteinases in heart disease. Cardiovasc Res 1996; 32: 816-21.
17. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-43.